• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

挪威癌症患者通道的公平获取 - 一项基于国家登记的研究。

Equitable access to cancer patient pathways in Norway - a national registry-based study.

机构信息

Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.

Centre for Clinical Documentation and Evaluation (SKDE), Northern Norway Regional Health Authority, Tromsø, Norway.

出版信息

BMC Health Serv Res. 2021 Nov 25;21(1):1272. doi: 10.1186/s12913-021-07250-1.

DOI:10.1186/s12913-021-07250-1
PMID:34823515
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8613926/
Abstract

BACKGROUND

In 2015, cancer patient pathways (CPP) were implemented in Norway to reduce unnecessary non-medical delay in the diagnostic process and start of treatment. The main aim of this study was to investigate the equality in access to CPPs for patients with either lung, colorectal, breast or prostate cancer in Norway.

METHODS

National population-based data on individual level from 2015 to 2017 were used to study two proportions; i) patients in CPPs without the cancer diagnosis, and ii) cancer patients included in CPPs. Logistic regression was applied to examine the associations between these proportions and place of residence (hospital referral area), age, education, income, comorbidity and travel time to hospital.

RESULTS

Age and place of residence were the two most important factors for describing the variation in proportions. For the CPP patients, inconsistent differences were found for income and education, while for the cancer patients the probability of being included in a CPP increased with income.

CONCLUSIONS

The age effect can be related to both the increasing risk of cancer and increasing number of GP and hospital contacts with age. The non-systematic results for CPP patients according to income and education can be interpreted as equitable access, as opposed to the systematic differences found among cancer patients in different income groups. The inequalities between income groups among cancer patients and the inequalities based on the patients' place of residence, for both CPP and cancer patients, are unwarranted and need to be addressed.

摘要

背景

2015 年,挪威实施了癌症患者路径(CPP),以减少诊断过程和治疗开始时不必要的非医疗延误。本研究的主要目的是调查挪威肺癌、结直肠癌、乳腺癌或前列腺癌患者获得 CPP 的平等情况。

方法

使用 2015 年至 2017 年的全国基于人群的个体水平数据,研究两个比例:i)未确诊癌症的 CPP 患者,ii)纳入 CPP 的癌症患者。应用逻辑回归检验这些比例与居住地(医院转诊区)、年龄、教育、收入、合并症和到医院的旅行时间之间的关联。

结果

年龄和居住地是描述比例变化的两个最重要因素。对于 CPP 患者,收入和教育的差异不一致,而对于癌症患者,纳入 CPP 的概率随收入增加而增加。

结论

年龄效应可能与癌症风险的增加以及与年龄相关的全科医生和医院接触次数的增加有关。根据收入和教育,CPP 患者的结果没有系统性差异,可以解释为平等获得,而不同收入组的癌症患者则存在系统差异。癌症患者的收入群体之间的不平等以及 CPP 和癌症患者的居住地之间的不平等都是不合理的,需要解决。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d675/8613926/10d1e1b1e02a/12913_2021_7250_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d675/8613926/61783b84c189/12913_2021_7250_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d675/8613926/18fefd0a53e2/12913_2021_7250_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d675/8613926/10d1e1b1e02a/12913_2021_7250_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d675/8613926/61783b84c189/12913_2021_7250_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d675/8613926/18fefd0a53e2/12913_2021_7250_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d675/8613926/10d1e1b1e02a/12913_2021_7250_Fig3_HTML.jpg

相似文献

1
Equitable access to cancer patient pathways in Norway - a national registry-based study.挪威癌症患者通道的公平获取 - 一项基于国家登记的研究。
BMC Health Serv Res. 2021 Nov 25;21(1):1272. doi: 10.1186/s12913-021-07250-1.
2
Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.2015-2016 年挪威癌症患者路径纳入相关的患者和肿瘤特征。
BMC Cancer. 2020 May 30;20(1):488. doi: 10.1186/s12885-020-06979-y.
3
Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015-2016.2015-2016 年,挪威癌症患者的癌症类型和居住地不同,其对推荐的癌症患者路径时间框架的遵守情况和治疗选择也不同。
BMC Cancer. 2022 Feb 28;22(1):220. doi: 10.1186/s12885-022-09306-9.
4
Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study.全科医疗中的癌症疑似病例、紧急转诊及诊断时间:一项基于人群的全科医生调查与登记研究。
BMC Cancer. 2014 Aug 30;14:636. doi: 10.1186/1471-2407-14-636.
5
Education, income and risk of cancer: results from a Norwegian registry-based study.教育、收入与癌症风险:一项基于挪威登记处研究的结果
Acta Oncol. 2020 Nov;59(11):1300-1307. doi: 10.1080/0284186X.2020.1817548. Epub 2020 Sep 14.
6
Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage.在全民医保的国家,肺癌的治疗受到收入、教育、年龄和居住地的影响。
Int J Cancer. 2016 Mar 15;138(6):1350-60. doi: 10.1002/ijc.29875. Epub 2015 Oct 20.
7
CPP or Not, That Is the Question: Physicians' Work With Activating CPPs.是否要 CPP,这是个问题:医生在激活 CPP 方面的工作。
Qual Health Res. 2021 Sep;31(11):2084-2096. doi: 10.1177/10497323211020708. Epub 2021 Jun 7.
8
Do parental education and income matter? A nationwide register-based study on HPV vaccine uptake in the school-based immunisation programme in Norway.父母的教育程度和收入重要吗?一项基于挪威全国登记系统的关于学校免疫计划中HPV疫苗接种情况的研究。
BMJ Open. 2015 May 19;5(5):e006422. doi: 10.1136/bmjopen-2014-006422.
9
Cancer suspicion, referral to cancer patient pathway and primary care interval: a survey and register study exploring 10 different types of abdominal cancer.癌症怀疑、转诊至癌症患者通道和初级保健间隔:一项探索 10 种不同类型腹部癌症的调查和登记研究。
Fam Pract. 2021 Sep 25;38(5):589-597. doi: 10.1093/fampra/cmab025.
10
Shared decision-making in standardized cancer patient pathways in Norway-Narratives of patient experiences.挪威标准化癌症患者路径中的共同决策——患者体验的叙述。
Health Expect. 2021 Oct;24(5):1780-1789. doi: 10.1111/hex.13317. Epub 2021 Jul 21.

引用本文的文献

1
Inclusion in the cancer patient pathway among cancer patients with and without pre-existing mental or substance use disorders: a nationwide register-based study.患有和未患有既往精神或物质使用障碍的癌症患者在癌症患者诊疗流程中的纳入情况:一项基于全国登记处的研究
BMC Public Health. 2025 May 29;25(1):1991. doi: 10.1186/s12889-025-23180-7.
2
"I Became the Messenger Between the Hospitals": A Study on the Journeys of People With Cancer Using the Critical Incident Technique.“我成为了医院之间的信使”:一项运用关键事件技术对癌症患者就医历程的研究。
Health Expect. 2025 Apr;28(2):e70211. doi: 10.1111/hex.70211.
3
Educational disparities in cancer incidence, stage, and survival in Oslo.

本文引用的文献

1
When time matters: a qualitative study on hospital staff's strategies for meeting the target times in cancer patient pathways.当时间至关重要:一项关于医院工作人员在癌症患者路径中达到目标时间的策略的定性研究。
BMC Health Serv Res. 2021 Mar 9;21(1):210. doi: 10.1186/s12913-021-06224-7.
2
A Nordic initiative for a more personal and accurate diagnostic pathway for prostate cancer.一项旨在为前列腺癌打造更个性化、更精准诊断路径的北欧倡议。
Scand J Prim Health Care. 2020 Sep;38(3):249-250. doi: 10.1080/02813432.2020.1801148.
3
Effects of replacing PSA with Stockholm3 for diagnosis of clinically significant prostate cancer in a healthcare system - the Stavanger experience.
奥斯陆市癌症发病率、分期及生存率方面的教育差异。
Res Health Serv Reg. 2024 Jan 29;3(1):1. doi: 10.1007/s43999-024-00037-x.
4
Effects of Demographic and Socio-Economic Factors on Investigation Time of Lung Cancer Patients in Denmark: A Retrospective Cohort Study.人口统计学和社会经济因素对丹麦肺癌患者检查时间的影响:一项回顾性队列研究
Health Serv Res Manag Epidemiol. 2023 Oct 24;10:23333928231206627. doi: 10.1177/23333928231206627. eCollection 2023 Jan-Dec.
用斯德哥尔摩 3 取代 PSA 对医疗保健系统中具有临床意义的前列腺癌诊断的影响-斯塔万格经验。
Scand J Prim Health Care. 2020 Sep;38(3):315-322. doi: 10.1080/02813432.2020.1802139. Epub 2020 Aug 8.
4
Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.2015-2016 年挪威癌症患者路径纳入相关的患者和肿瘤特征。
BMC Cancer. 2020 May 30;20(1):488. doi: 10.1186/s12885-020-06979-y.
5
Implementing standardized cancer patient pathways (CPPs) - a qualitative study exploring the perspectives of health care professionals.实施标准化癌症患者路径(CPPs)-一项探索医疗保健专业人员观点的定性研究。
BMC Health Serv Res. 2019 Aug 16;19(1):577. doi: 10.1186/s12913-019-4413-6.
6
Decreasing waiting time for treatment before and during implementation of cancer patient pathways in Norway.在挪威实施癌症患者路径之前和期间,减少治疗前的等待时间。
Cancer Epidemiol. 2019 Aug;61:59-69. doi: 10.1016/j.canep.2019.05.004. Epub 2019 May 27.
7
The breast cancer paradox: A systematic review of the association between area-level deprivation and breast cancer screening uptake in Europe.乳腺癌悖论:欧洲地区层面贫困与乳腺癌筛查接受情况之间关联的系统评价
Cancer Epidemiol. 2019 Jun;60:77-85. doi: 10.1016/j.canep.2019.03.008. Epub 2019 Mar 28.
8
The national program on standardized cancer care pathways in Sweden: Observations and findings half way through.瑞典国家标准化癌症护理路径计划:中期观察和发现。
Health Policy. 2018 Sep;122(9):945-948. doi: 10.1016/j.healthpol.2018.07.012. Epub 2018 Jul 20.
9
The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential.《前列腺癌检测的斯德哥尔摩-3 模型:算法更新、生物标志物贡献和反射测试潜力》
Eur Urol. 2018 Aug;74(2):204-210. doi: 10.1016/j.eururo.2017.12.028. Epub 2018 Jan 10.
10
Prognostic consequences of implementing cancer patient pathways in Denmark: a comparative cohort study of symptomatic cancer patients in primary care.丹麦实施癌症患者路径的预后后果:初级保健中症状性癌症患者的对比队列研究。
BMC Cancer. 2017 Sep 6;17(1):627. doi: 10.1186/s12885-017-3623-8.